The interaction between IL-1β and morphine: Possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice

Pain

Volumn 89, Issue 1, 2000, Pages 39-45

  Gul, Husamettin ^a   Yildiz, Oguzhan ^a   Dogrul, Ahmet ^a   Yesilyurt, Ozgur ^a   Isimer, Askin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Diabetes; Interleukin 1 beta; Mice; Morphine; Streptozotocin

Indexed keywords

INTERLEUKIN 1BETA; MORPHINE; INTERLEUKIN 1; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG SENSITIVITY; HYPERALGESIA; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE; STREPTOZOCIN DIABETES; TAIL FLICK TEST; ANIMAL; BAGG ALBINO MOUSE; BODY TEMPERATURE; DRUG EFFECT; DRUG INTERACTION; EXPERIMENTAL DIABETES MELLITUS; IMMUNOLOGY; METABOLISM; PAIN; PAIN THRESHOLD; PHYSIOLOGY; RECTUM; TAIL;

ANALGESICS, OPIOID; ANIMALS; BODY TEMPERATURE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INTERLEUKIN-1; MALE; MICE; MICE, INBRED BALB C; MORPHINE; PAIN; PAIN THRESHOLD; RECTUM; TAIL;

EID: 0034670391     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00343-2     Document Type: Article

References (45)

1. Passage of cytokines across the blood-brain barrier
2. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
3. Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain
4. Central activation of thermogenesis and fever by interleukin-1 beta and interleukin-1 alpha involves different mechanisms
5. In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients
6. Pyrogenic and thermogenic effects of interleukin-1 beta in the rat
7. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests
8. Interleukin-1 and interleukin-1 antagonism
9. Binding affinity and selectivity of opioids at mu, delta, and kappa receptors in monkey brain membranes
10. Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following initial insulin treatment
11. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue
12. Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia
13. Streptozotocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 weeks in female rats
14. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat
15. Neuropathic pain of peripheral origin: advances in pharmacologic treatment
16. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
17. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM
18. Painful diabetic peripheral neuropathy. A stepwise approach to treatment
19. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists
20. Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice
21. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices
22. Obligatory role of B cells and adherent accessory cells in the transfer of a defect in morphine-mediated antinociception in C57BL/6J-bg/bg (beige-J) mice
23. Fever: role of pyrogens and cryogens
24. Sleep-promoting effects of endogenous pyrogen (interleukin-1)
25. Pain threshold in diabetic rats: effects of good versus poor diabetic control
26. Cytokine production in patients with newly diagnosed insulin-dependent (type I) diabetes mellitus
27. C57BL/6J-bgj (beige) mice: differential sensitivity in the tail flick test to centrally administered mu- and delta-opioid receptor agonists
28. Convulsants induce interleukin-1 beta messenger RNA in rat brain
29. Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus
30. Serum levels of tumor necrosis factor and IL-1 alpha and IL-1 beta in diabetic patients
31. Anorexic effects of interleukin-1 in the rat
32. Interleukin-1 induces analgesia in mice by a central action
33. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals
34. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus
35. Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats
36. Interleukin 1 alters rat sleep: temporal and dose related effects
37. Interleukin-1 beta depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations
38. The combined immunological and antinociceptive defects of beige-j mice: the possible existence of a 'μ-repression'
39. Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats
40. Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels
41. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine
42. Biphasic effects of intracerebroventricular interleukin-1 beta on mechanical nociception in the rat
43. Involvement of central beta-adrenoceptors in the induction of hypothalamic interleukin-1 beta mRNA by methamphetamine
44. Interleukin-1 beta inhibits synaptic transmission and induces membrane hyperpolarization in amygdala neurons
45. Ethical guidelines for investigations of experimental pain in conscious animals